BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 2893729)

  • 1. Distribution of somatostatin receptors in RINm5F insulinoma cells.
    Sullivan SJ; Schonbrunn A
    Endocrinology; 1988 Mar; 122(3):1137-45. PubMed ID: 2893729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of somatostatin receptors which mediate inhibition of insulin secretion in RINm5F insulinoma cells.
    Sullivan SJ; Schonbrunn A
    Endocrinology; 1987 Aug; 121(2):544-52. PubMed ID: 2885182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The processing of receptor-bound [125I-Tyr11]somatostatin by RINm5F insulinoma cells.
    Sullivan SJ; Schonbrunn A
    J Biol Chem; 1986 Mar; 261(8):3571-7. PubMed ID: 2869033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.
    Presky DH; Schonbrunn A
    Mol Pharmacol; 1988 Nov; 34(5):651-8. PubMed ID: 2904115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a biotinylated somatostatin analog as a receptor probe.
    Schonbrunn A; Lee AB; Brown PJ
    Endocrinology; 1993 Jan; 132(1):146-54. PubMed ID: 8093437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic beta-cell somatostatin receptors.
    Thermos K; Meglasson MD; Nelson J; Lounsbury KM; Reisine T
    Am J Physiol; 1990 Aug; 259(2 Pt 1):E216-24. PubMed ID: 1974386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterisation of heterogeneous somatostatin binding sites in rat distal colonic mucosa.
    McKeen ES; Feniuk W; Michel AD; Kidd EJ; Humphrey PP
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):543-9. PubMed ID: 8938650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretion in vivo and in vitro from transplantable NEDH rat insulinoma and derived clonal RINm5F cell line.
    Flatt PR; DeSilva M; Swanston-Flatt SK; Marks V
    Diabetes Res; 1987 Oct; 6(2):85-90. PubMed ID: 2827934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of covalently cross-linked somatostatin receptors in hamster beta cell insulinoma.
    Cotroneo P; Marie JC; Rosselin G
    Eur J Biochem; 1988 May; 174(1):219-24. PubMed ID: 2897292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
    Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW
    J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis.
    Heiman ML; Murphy WA; Coy DH
    Neuroendocrinology; 1987 Jun; 45(6):429-36. PubMed ID: 2886933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific high affinity binding sites for somatostatin-28 on pancreatic beta-cells: differences with brain somatostatin receptors.
    Reubi JC; Rivier J; Perrin M; Brown M; Vale W
    Endocrinology; 1982 Mar; 110(3):1049-51. PubMed ID: 6120075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of somatostatin receptors by covalent labeling with a novel photoreactive somatostatin analog.
    Brown PJ; Lee AB; Norman MG; Presky DH; Schonbrunn A
    J Biol Chem; 1990 Oct; 265(29):17995-8004. PubMed ID: 1976633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of binding sites for oxyntomodulin on a somatostatin-secreting cell line (RIN T3).
    Gros L; Demirpence E; Jarrousse C; Kervran A; Bataille D
    Endocrinology; 1992 Mar; 130(3):1263-70. PubMed ID: 1371446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors.
    Hoyer D; Pérez J; Schoeffter P; Langenegger D; Schüpbach E; Kaupmann K; Lübbert H; Bruns C; Reubi JC
    Eur J Pharmacol; 1995 Mar; 289(1):151-61. PubMed ID: 7781706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase.
    Epelbaum J; Enjalbert A; Krantic S; Musset F; Bertrand P; Rasolonjanahary R; Shu C; Kordon C
    Endocrinology; 1987 Dec; 121(6):2177-85. PubMed ID: 2890515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrient induced insulin release from an insulinoma derived B-cell line.
    Lambert DG; Atkins TW
    Acta Diabetol Lat; 1987; 24(4):299-304. PubMed ID: 2830753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding sites for peptide-histidine-isoleucine (PHI) on rat insulinoma-derived RINm5F cells.
    Göke R; Conlon JM
    Mol Cell Endocrinol; 1988 Dec; 60(2-3):211-5. PubMed ID: 2850958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes.
    Koch BD; Schonbrunn A
    Endocrinology; 1984 May; 114(5):1784-90. PubMed ID: 6143660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucagon-like peptide-1 (GLP-1) in RINm5F insulinoma cells. Stimulation of insulin secretion, insulin content, and insulin receptor binding.
    Jehle PM; Jehle D; Fussgänger RD; Adler G
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():31-6. PubMed ID: 8839251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.